FEASIBILITY OF USING A FACTORY-CALIBRATED CGM SYSTEM TO DIAGNOSE TYPE 2 DIABETES

被引：0
作者：
Frank, S. [1 ]
Hames, K. [2 ]
Jbaily, A. [1 ]
Welsh, J. [2 ]
Stroyeck, C. [1 ]
Price, D. [1 ]
机构：
[1] Dexcom Inc, Data Sci, San Diego, CA USA
[2] Dexcom Inc, Clin Affairs, San Diego, CA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O075 / #50
引用
收藏
页码：A48 / A48
页数：1
相关论文
共 50 条
  • [41] GlucoMen Day CGM System Accuracy Assessment in Individuals with Type 1 Diabetes
    Simic, Amra
    Taucher, Marlene T.
    Hochfellner, Daniel A.
    Poettler, Tina
    Aberer, Felix
    Mader, Julia K.
    DIABETES, 2021, 70
  • [42] Glucomen Day® CGM system accuracy assessment in individuals with type 1 diabetes
    Simic, Amra
    Taucher, Marlene
    Hochfellner, Daniel
    Poettler, Tina
    Aberer, Felix
    Mader, Julia
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 200 - 200
  • [43] Perceived Barriers to Physical Activity in People with Type 1 Diabetes Using CGM
    Andre, Camille C.
    Kudva, Yogish C.
    Dadlani, Vikash
    Cescon, Marzia
    Mccrady-Spitzer, Shelly K.
    Church, Mei Mei
    Reid, Corey
    Kumari, Kanchan
    Choudhary, Divya
    Doyle, Francis J., III
    Dassau, Eyal
    Pinsker, Jordan E.
    DIABETES, 2019, 68
  • [44] Investigation of Usefulness of Continuous Glucose Monitoring System (CGM) in Outpatient Care of Japanese Patients with Type 2 Diabetes
    Sato, Junko
    Kanazawa, Akio
    Ikeda, Fuki
    Shigihara, Nayumi
    Kawaguchi, Minako
    Komiya, Koji
    Uchida, Toyoyoshi
    Ogihara, Takeshi
    Shimizu, Tomoaki
    Fujitani, Yoshio
    Watada, Hirotaka
    DIABETES, 2014, 63 : A215 - A215
  • [45] USE OF CGM WITH PEOPLE WITH DIABETES TYPE 2 TREATED WITH BASAL INSULIN ONLY
    Leelarathna, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A2 - A2
  • [46] Estimating Optimal CGM Wear Time for Individuals with Type 2 Diabetes Not on Insulin
    Barua, Souptik
    Upadhyay, Dhairya A.
    Curran, Margaret
    Berube, Lauren
    Popp, Collin
    Pompeii, Mary Lou
    Wang, Josephine C.
    Vanegas, Sally M.
    Dorcely, Brenda
    Hu, Lu
    St-Jules, David
    Bergman, Michael
    Segal, Eran
    Sevick, Mary Ann
    DIABETES, 2024, 73
  • [47] Correlates of CGM Uptake among Adults with Type 2 Diabetes in Primary Care
    Mayberry, Lindsay S.
    Roddy, Mckenzie K.
    Jaser, Sarah S.
    Elasy, Tom A.
    DIABETES, 2022, 71
  • [48] ACCURACY ASSESSMENT OF THE NEW GLUCOMEN® DAY CGM SYSTEM IN INDIVIDUALS WITH TYPE 1 DIABETES
    Simic, A.
    Taucher, M.
    Hochfellner, D.
    Dietrich, M.
    Poerttler, T.
    Aberer, F.
    Mader, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A117 - A117
  • [49] Monitoring Stage 2 to Stage 3 Transition in Type 1 Diabetes Using Continuous Glucose Monitoring (CGM)
    Frohnert, Brigitte I.
    Sepulveda, Flor
    Stoughton, Jessica E.
    Steck, Andrea
    Simmons, Kimber M.
    DIABETES, 2023, 72
  • [50] Pilot Study on the Feasibility of Weekly CGM Data Review in Youth with New-Onset Type 1 Diabetes
    Lee, Ming Yeh
    Leverenz, Jeannine
    Leverenz, Brianna
    Pageler, Natalie M.
    Scheinker, David
    Maahs, David M.
    Prahalad, Priya
    DIABETES, 2020, 69
12345